Clinical Trials Sponsored by LifeWatch Services, Inc.

Total 545 results

LifeWatch Services, Inc.

Completed

Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting (VSP)

Automated Measurement of Vital Signs

United States
LifeWatch Services, Inc.

Completed

Vital Signs Patch Early Feasibility and Usability Study v1.0 (VSP)

Vital Signs

United States
LifeWatch Services, Inc.

Terminated

Proof of Concept Study for 1 Lead Patch Technology

Telemetry

United States
LifeWatch Services, Inc.

Completed

Vital Signs Patch Early Feasibility and Usability Study (VSP)

Vital Signs

United States
LifeWatch Services, Inc.

Completed

Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)

Desaturation of Blood

United States
Northwestern University
LifeWatch Services, Inc.

Completed

Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism

Stroke | Atrial Fibrillation

United States
Jazz Pharmaceuticals
Dana-Farber Cancer Institute; Celerion; LifeWatch Services, Inc.

Completed

Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

Healthy

United States
Lyssn.io, Inc.
ProtoCall Services, Inc.

Not yet recruiting

The Use of Voice-Based AI in 988 Crisis Counseling

Suicide | Suicide and Self-harm
Advanced Laboratory Services, Inc.

Terminated

A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease (ALSIBDT)

Lyme Disease

United States
OMNI Medical Services, LLC
OMNI Medical Services Inc

Recruiting

Outcomes Mandate National Integration With Cannabis as Medicine (OMNI-Can)

Depression | COVID-19 | Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Covid19 | Chronic Pain | Parkinson Disease | Inflammatory Bowel Diseases | Hepatitis C | Insomnia | HIV/AIDS | Amyotrophic Lateral Sclerosis | Fibromyalgia | Anxiety | Bipolar Disorder | Seizures | Crohn Disease | Traumatic Brain Injury | Ulcerative Colitis | Sickle... and other conditions

United States
Fujirebio Diagnostics, Inc.
Advanced Clinical Research Services, LLC; ReSearch Pharmaceutical Services,...

Completed

Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

Ovarian Cancer | Adnexal Mass

United States
Carl Zeiss Meditec, Inc.
ClinReg Consulting Services, Inc.; Sierra Clinical Services, LLC

Completed

Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam

Cornea

United States
Providence Health & Services
Genentech, Inc.

Completed

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab (PRECEPT)

Multiple Sclerosis | Infusion Reaction

United States
United Health Services Hospitals, Inc.

Enrolling by invitation

Triamcinolone Ketorolac (TriKe) Knee Trial (TriKe)

Osteoarthritis, Knee

United States
RAND
Bienestar Human Services, Inc.

Completed

A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM

HIV

United States
Providence Health & Services
Genentech, Inc.

Completed

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab (OCTAVE)

Relapsing Remitting Multiple Sclerosis

United States
Orlucent, Inc
Clalit Health Services

Completed

Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

Skin Lesions
RAND
Behavioral Health Services, Inc.

Completed

Group CBT for Depression and AOD Disorders (BRIGHT2)

Depression | Substance Use

United States
Providence Health & Services
Inhibrx, Inc.

Not yet recruiting

Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients

Triple Negative Breast Cancer

United States
RAND
Bienestar Human Services, Inc.

Recruiting

A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men

HIV

United States
Providence Health & Services
Seagen Inc.

Withdrawn

Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (2019-101826)

Breast Cancer Stage IV

United States
Abinopharm, Inc
ProRelix Services LLP

Completed

To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults

Aging

India
Allgenesis Biotherapeutics Inc.
Lexitas Pharma Services, Inc.

Active, not recruiting

AG-73305 Single Ascending Dose Cohort Study in DME

Diabetic Macular Edema

United States
Eko Devices, Inc.

Recruiting

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

Pulmonary Hypertension

United States
Eko Devices, Inc.

Recruiting

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

Atrial Fibrillation | Heart Murmurs | Murmur, Heart | Innocent Murmurs | Pathologic Murmur

United States
Eko Devices, Inc.

Recruiting

Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting

Heart Murmurs | Murmur, Heart | Innocent Murmurs | Pathologic Murmur

United States
Eko Devices, Inc.

Completed

Detection of Heart Conditions Using Artificial Intelligence

Heart Failure | Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Completed

Low Ejection Fraction in Single Lead ECG

Heart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Completed

Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes

Aortic Valve Stenosis | Mitral Regurgitation | Heart Murmurs | Tricuspid Regurgitation | Murmur, Heart | Innocent Murmurs

United States
Eko Devices, Inc.

Completed

Low Ejection Fraction in Single Lead ECG- Ochsner

Heart Diseases | Cardiovascular Diseases | Ventricular Dysfunction | Left Ventricular Dysfunction

United States
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Recruiting

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

RSV Infection

United Kingdom
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.

Food-drug Interaction

Canada
Providence Health & Services
Galectin Therapeutics Inc.

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Melanoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

United States
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Completed

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

RSV Infection

United Kingdom
Aucta Technologies, Inc.
STATKING Clinical Services

Suspended

Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia

Diabetes Mellitus, Type 2

United States
The Herb, Inc
ProRelix Services LLP

Completed

Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)

Covid19

India
Spartan Bioscience Inc.
Mount Sinai Services

Completed

Spartan Cube CYP2C19 Method Comparison Study

Genotyping Techniques

Canada
Eko Devices, Inc.

Completed

Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence (DAVID1)

Left Ventricular Dysfunction

United States
Eko Devices, Inc.

Terminated

Heart Failure Monitoring With Eko Electronic Stethoscopes (HOME0)

Heart Failure | Heart Failure With Preserved Ejection Fraction | Crackles

United States
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

Multiple Drug Use

Canada
Community Pharmacology Services Ltd
Pulmatrix Inc.

Withdrawn

Allergic Bronchopulmonary Aspergillosis Prescreening Study

Asthma | Allergic Bronchopulmonary Aspergillosis | ABPA

United Kingdom
Unicity International, Inc.
Biofortis Innovation Services

Completed

Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability

Healthy | Impaired Glucose Tolerance

United States
Inova Health Care Services
Genentech, Inc.

Withdrawn

ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma

Stage IIIB-C Melanoma

United States
Nutrasource Pharmaceutical and Nutraceutical Services...

Completed

Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream

Thigh Cellulite

Canada
Nutrasource Pharmaceutical and Nutraceutical Services...

Completed

Effect of a Natural Health Product on Urinary Estrogen Metabolites

Breast Cancer

Canada
Cocrystal Pharma, Inc.
hVIVO Services Limited

Recruiting

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Influenza A

United Kingdom
Desitin Arzneimittel GmbH
BioPharma Services, Inc

Completed

Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions

Fasting

Canada
Inova Health Care Services
Natera, Inc.

Withdrawn

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

United States
SQ Innovation, Inc.
Accel Clinical Services

Completed

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Heart Failure

United States
Providence Health & Services
Aduro Biotech, Inc.

Completed

Phase I Study of Safety and Immunogenicity of ADU-623

Brain Tumor | Glioblastoma Multiforme | Anaplastic Astrocytoma | Astrocytic Tumors

United States

Clinical Trials Sponsored by LifeWatch Services, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations